Here are relevant reports on : human-resource-technology-market

• Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

  The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.

  • Published: December 2024
  • Price: $ 4950
  • TOC Available:

• Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)

  The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025

  The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).

  • Published: July 2020
  • Price: $ 4950
  • TOC Available:

• AI Avatar Market by Platform (Digital Human, 3D & Metaverse Avatars, Stylized Avatars), Type (Interactive Avatars, Noninteractive Avatars), Application (Virtual Assistant, Characters, Influencer, Companion, Podcaster & VTuber) - Global Forecast to 2032

  The AI avatar market is expanding rapidly, with a projected market size anticipated to rise from USD 0.80 billion in 2025 to USD 5.93 billion by 2032, featuring a CAGR of 33.1%. The major players in the AI avatar market include Synthesia (UK), HeyGen (US), D-ID (Israel), Akool (US), Veritone (US), NVIDIA (US), AWS (US), Meta (US), Vyond (US), and Soul Machines (US).

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Swarm Intelligence Market by Model, Capability (Clustering, Routing, Scheduling, and Optimization), Application (Robotics, Drones, and Human Swarming), and Geography - Global Forecast to 2030

  The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The estimated year considered for the study is 2020, and the forecast period is between 2020 and 2023. The report profiles the most promising players in this market. The key players in this market are DoBots (Netherlands), Hydromea (Switzerland), Sentien Robotics (US), Unanimous A.I. (US), AxonAI (US), Swarm Technology (US), SSI Schäfer - Fritz Schäfer (Germany), Valutico (Austria), Enswarm (UK), and Power-Blox (Switzerland).

  • Published: November 2017
  • Price: $ 4950
  • TOC Available:

• Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029

  The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities

  • Published: December 2024
  • Price: $ 4950
  • TOC Available:

• Fish Oil Market for Aquaculture, Direct Human Consumption, Hydrogenation & Industrial Applications - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018

  • Published: January 2026
  • Price: $ 4950
  • TOC Available:

• Defense Electronics Obsolescence Market by System (Communication System; Navigation System; Human Machine Interface; Flight Control System; Targeting System; Electronic Warfare System; and Sensors), Type & Region - Global Forecast to 2028

  The defense electronics obsolescence market is expected to grow from USD 2.5 billion in 2023 to USD 3.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.2% during the forecast period.The key players Raytheon Technologies Corporation (US), BAE Systems (UK), L3Harris Technologies, Inc. (US), Thales (US) and Elbit Systems Ltd. (Israel).

  • Published: March 2024
  • Price: $ 4950
  • TOC Available:

• Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029

  The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.

  • Published: March 2024
  • Price: $ 4950
  • TOC Available:

• Wealth Management Platform Market by Advisory Model (Human Advisory, Robo Advisory, and Hybrid), Business Function (Reporting, Portfolio, Accounting, and Trading Management), Deployment Model, End-User Industry, and Region - Global Forecast to 2022

  The global wealth management platform market size is expected to grow from USD 1.70 Billion in 2017 to USD 3.20 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. The wealth management platform ecosystem comprises vendors, such as SS&C Technologies, Inc. (US), Fiserv, Inc. (US), Fidelity National Information Services (US), Profile Software (UK), Broadridge Financial Solutions, Inc. (US), InvestEdge, Inc. (US), Temenos Group AG (Switzerland), Finantix S.p.A. (Italy), SEI Investments Company (US), Comarch SA (Poland), Objectway S.p.A. (Italy), and Dorsum Ltd. (Hungary). The other stakeholders of the wealth management platform market include managed service providers, third-party providers, and technology providers.

  • Published: March 2018
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50